ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
232 |
51K |
23 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
232
|
51K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
232 |
51K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
232
|
51K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
232 |
51K |
11 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
51K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
232 |
51K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
51K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Cashtrain
|
21 |
5.6K |
3 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
21
|
5.6K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Cashtrain
|
21 |
5.6K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
21
|
5.6K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Cashtrain
|
21 |
5.6K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
21
|
5.6K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
1.2K |
296K |
12 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.2K
|
296K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
1.2K |
296K |
12 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.2K
|
296K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.6K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.6K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.6K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.6K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
18K |
9 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
18K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
18K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
18K |
11 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
18K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
1.2K |
296K |
11 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.2K
|
296K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Cashtrain
|
55 |
14K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Cashtrain
|
55 |
14K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Cashtrain
|
31 |
10K |
4 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
10K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Cashtrain
|
31 |
10K |
14 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
10K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Cashtrain
|
31 |
10K |
9 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
10K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Cashtrain
|
282 |
73K |
10 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
282
|
73K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Cashtrain
|
197 |
51K |
21 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
51K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Cashtrain
|
126 |
31K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Cashtrain
|
126 |
31K |
16 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
31K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
8 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
7 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
196 |
36K |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
311 |
77K |
8 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
311
|
77K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Cashtrain
|
63 |
16K |
14 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
16K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Cashtrain
|
39 |
9.2K |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.2K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Cashtrain
|
282 |
73K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
282
|
73K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Cashtrain
|
39 |
9.2K |
9 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
9.2K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
17 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
58
|
14K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
15 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
10 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
21 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
10 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Cashtrain
|
77 |
19K |
8 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
77
|
19K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
311 |
77K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
77K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
311 |
77K |
13 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
311
|
77K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
311 |
77K |
3 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
311
|
77K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
311 |
77K |
6 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
311
|
77K
|
6
|
|